Pan American Pharmaceutical Industry Association
GPTKB entity
Properties (70)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Association
|
| gptkbp:addresses |
Healthcare challenges
|
| gptkbp:advocatesFor |
Research funding
Patient safety Intellectual property rights Health equity Access to medicines Affordable healthcare Sustainable healthcare solutions Quality assurance in pharmaceuticals |
| gptkbp:aimsTo |
Reduce healthcare disparities
Improve public health Enhance patient outcomes Enhance pharmaceutical standards Foster_innovation_in_healthcare Strengthen_healthcare_systems |
| gptkbp:collaboratesWith |
Government agencies
Research organizations Non-governmental organizations Industry associations |
| gptkbp:encourages |
Investment in healthcare
|
| gptkbp:engagesIn |
Community outreach
Capacity building Public awareness campaigns Stakeholder consultations Advocacy efforts Policy dialogue |
| gptkbp:established |
2000
|
| gptkbp:focusesOn |
Pharmaceutical industry
|
| gptkbp:fosters |
Partnerships among stakeholders
|
| gptkbp:hasHistoricalSignificance |
gptkb:Washington,_D.C.
|
| gptkbp:hosts |
Workshops
Conferences and seminars |
| https://www.w3.org/2000/01/rdf-schema#label |
Pan American Pharmaceutical Industry Association
|
| gptkbp:influences |
Regulatory policies
|
| gptkbp:members |
Pharmaceutical companies
|
| gptkbp:participatesIn |
Health initiatives
Trade shows Public health campaigns International forums Health policy discussions |
| gptkbp:promotes |
Access to healthcare services
Patient-centered care Innovation in pharmaceuticals Collaboration in research Ethical_practices Sustainable_practices |
| gptkbp:provides |
Networking opportunities
Training programs Policy recommendations Technical assistance Advocacy training Guidance on regulations Information resources Best practice guidelines |
| gptkbp:publishes |
Reports and studies
|
| gptkbp:region |
gptkb:Pan_America
|
| gptkbp:supports |
Research and development
Clinical trials Global health initiatives Health technology assessment Innovation in drug development Pharmaceutical education Pharmaceutical supply chain integrity Access to quality medicines |
| gptkbp:worksWith |
Academic institutions
Health authorities International health organizations Pharmaceutical regulators Healthcare_professionals |